Poloxamer 407, an FDA-approved polymer whose properties can be reversed by heating, is injected at the site where the blood vessels are to be joined, and the area is heated.
The Poloxamer 407 becomes elastic and solid when heated, causing openings of a severed blood vessel to become distended so that surgeons can precisely join the openings together with Dermabond, a commonly used surgical sealant.
Related Articles on Medical Innovations:
CTQ Solutions Announces 2011 Apex Quality Award Winners for Healthcare Excellence
